Wanbangde Pharmaceutical Holding Group Balance Sheet Health
Financial Health criteria checks 3/6
Wanbangde Pharmaceutical Holding Group has a total shareholder equity of CN¥2.8B and total debt of CN¥1.0B, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are CN¥4.4B and CN¥1.6B respectively. Wanbangde Pharmaceutical Holding Group's EBIT is CN¥61.5M making its interest coverage ratio 1.4. It has cash and short-term investments of CN¥192.2M.
Key information
36.0%
Debt to equity ratio
CN¥1.00b
Debt
Interest coverage ratio | 1.4x |
Cash | CN¥192.24m |
Equity | CN¥2.79b |
Total liabilities | CN¥1.62b |
Total assets | CN¥4.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002082's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 002082's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥184.4M).
Debt to Equity History and Analysis
Debt Level: 002082's net debt to equity ratio (29.1%) is considered satisfactory.
Reducing Debt: 002082's debt to equity ratio has increased from 30.5% to 36% over the past 5 years.
Debt Coverage: 002082's debt is not well covered by operating cash flow (13.8%).
Interest Coverage: 002082's interest payments on its debt are not well covered by EBIT (1.4x coverage).